Rob has a comprehensive broad-based corporate practice that involves counseling clients on public and private securities offerings, securities law compliance, mergers and acquisitions, corporate finance, structured finance, private equity and corporate governance. Rob regularly represents investment banks and issuers in private placements, initial public offerings and follow-on offerings for emerging and established companies, primarily in technology and healthcare markets. Rob's corporate finance practice includes both bank and borrower representation, from single-lender to large syndicated financings, secured and unsecured, and workouts and restructurings.

Representative Client Work

  • $20.7 million offering of common stock and warrants issued by a biopharmaceutical company developing drugs designed to activate a patient's immune system against cancer

  • $30 million U.S. public offering of a foreign emerging pharmaceutical company
  • $35 million U.S. initial public offering of a foreign orphan drug pharmaceutical company
  • $47 million U.S. public offering of American depositary shares of a foreign medical device manufacturer
  • Represented the administrative agent and lead arranger of $500 million secured credit facility
  • Represented public and private pension, family office and fund-of-funds investors in connection with private equity investments and secondary market purchases and sales of partnership interests
  • Represented lessees, lessors and investors in lease, equipment and project financings, with particular experience in cross-border utility lease transactions, and in domestic aircraft, railcar and solar leasing
  • Provide corporate support to real estate practice group in entity formation, special purpose entity requirements and syndications

Bar & Court Admissions

  • New York

Education

  • J.D., Fordham University School of Law
  • B.A., Skidmore College

Community Engagement

  • New York State Bar Association

Awards & Honors

The Legal 500 U.S. (2016)

Practices

Jump to Page